Ibrutinib for treating relapsed or refractory mantle cell lymphoma

Final appraisal determination: 1

Committee papers (PDF 2.38 MB)

Final appraisal determination document (PDF 523 KB)

Draft guidance: 2

Appraisal consultation document 2 (PDF 423 KB)

Draft guidance

Committee papers (PDF 11.64 MB)

Appraisal consultation document (PDF 290 KB)

Committee papers presentation slides (PDF 328 KB)

Final scope (PDF 142 KB)

Final matrix (PDF 101 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 187 KB)

Draft scope (post-referral) (PDF 146 KB)

Draft scope for consultation (pre-referral) July 2014

Provisional matrix (pre-referral) July 2014